Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies
Blood Adv
.
2023 Jul 11;7(13):3146-3149.
doi: 10.1182/bloodadvances.2022009039.
Authors
Mazie Tsang
1
,
Kara Bischoff
2
,
Kelly L Schoenbeck
1
3
,
Kim Berry
4
,
David O'Riordan
2
,
Bita Fakhri
5
,
Sandy W Wong
1
,
Nina Shah
1
,
Rebecca Olin
1
,
Charalambos Andreadis
1
,
Jules Vieaux
2
,
Eve Cohen
2
,
Nancy Shepard Lopez
2
,
Gabriel N Mannis
5
,
Michael Rabow
2
Affiliations
1
Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA.
2
Division of Palliative Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA.
3
Division of Hematology and Oncology, Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, CA.
4
Executive Finance Consultant, Department of Medicine, University of California San Francisco, San Francisco, CA.
5
Division of Hematology, Department of Medicine, Stanford University, Stanford, CA.
PMID:
36809787
PMCID:
PMC10362539
DOI:
10.1182/bloodadvances.2022009039
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Ambulatory Care
Hematologic Neoplasms* / therapy
Humans
Outpatients
Palliative Care*
Patient Acceptance of Health Care
Grants and funding
T32 AG000212/AG/NIA NIH HHS/United States